2010_肾癌.pdf

格式: pdf 页数: 27 文件大小: 1MB 侵权/举报
2010_肾癌.pdf

2010_肾癌.pdf

格式: pdf 页数: 27 文件大小: 1MB
2010_肾癌.pdf Copyright © National Comprehensive Cancer Network 2010. All rights reserved. “NCCN”, the NCCN logo, and “National Comprehensive Cancer Network” are registered trademarks of the National Comprehensive Cancer Network. The Chinese edition of NCCN Clinical Practice Guidelines in Oncology-Kidney Cancer Guideline 2010 is the Chinese adapted version of NCCN Clinical Practice Guidelines in Oncology-Kidney Cancer Guideline, V.2.2010 as permitted and endorsed by NCCN. It is the collaborative outcome of the National Comprehensive Cancer Network and Chinese key opinion leaders of the field. The original guideline and Chinese edition are both available at: http://www.nccn.org. To view the most recent and complete version of the guideline, go online to www.nccn.org. These Guidelines and illustrations herein may not be reproduced in any form for any purpose without the express written permission of the NCCN. These Guidelines are a work in progress that will be refined as often as new significant data becomes available. The NCCN Guidelines are a statement of consensus of its authors regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult any NCCN guideline is expected to use independent medical judgment in the context of individual clinical circumstance to determine any patient's care or treatment. The National Comprehensive Cancer Network makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way. This publication should not be used for commercial purpose. It is provided for free to Chinese medical professions with the support of the unrestrictive educational grant of Bayer Healthcare Co. Ltd. which exerts no influence to the formation of the Chinese edition of NCCN Clinical Practice Guidelines in Oncology-Kidney Cancer Guideline 2010. NCCN ® 肿瘤学临床实践指南(中国版)2010年 第一版 © National Comprehensive Cancer Network, Inc. All rights reserved. These guidelines and this illustration may not be reproduced in any form without the express written permission of NCCN. The Chinese edition 2010 is the collaborative outcome of the National Comprehensive Cancer Network and Chinese key opinion leaders of the field. Translated and adapted with permission and endorsement from the National Comprehensive Cancer Network. To view the most recent and complete version of this or any other guideline, visit www.nccn.org. 肾癌 NCCN肾癌专家组成员 † 肿瘤内科 ‡ 血液科/血液肿瘤科 § 放射治疗/肿瘤放射科 ф 诊断放射科 £ 支持治疗,包括姑息治疗、 疼痛治疗、 关怀治疗和肿瘤社会工作 Þ 内科 ω 泌尿科 * 编委会成员 * Robert J. Motzer, MD/Chair † Þ Memorial Sloan-Kettering Cancer Center Neeraj Agarwal, MD ‡ Huntsman Cancer Institute at the University of Utah Clair Beard, MD § Dana-Farber/Brigham and Women’s Cancer Center Sam Bhayani, MD ω Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine Graeme B. Bolger, MD † University of Alabama at Birmingham Comprehensive Cancer Center Barry Boston, MD † £ St. Jude Children’s Research Hospital/University of Tennessee Cancer Institute Michael A. Carducci, MD † Þ The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Sam S. Chang, MD ω Vanderbilt-Ingram Cancer Center Toni K. Choueiri, MD † Þ Dana-Farber/Brigham and Women’s Cancer Center Robert A. Figlin, MD † City of Hope Comprehensive Cancer Certer Mayer Fishman, MD, PhD † ‡ Þ H. Lee Moffitt Cancer Center & Research Institute Steven L. Hancock, MD § Þ Stanford Comprehensive Cancer Center Gary R. Hudes, MD † ‡ Fox Chase Cancer Center Eric Jonasch, MD † The University of Texas M. D. Anderson Cancer Center Timothy M. Kuzel, MD † ‡ Robert H. Lurie Comprehensive Cancer Center of Northwestern University Paul H. Lange, MD ω Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance Ellis G. Levine, MD † Roswell Park Cancer Institute Kim A. Margolin, MD † ‡ Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance M. Dror Michaelson, MD, PhD † Massachusetts General Hospital Cancer Center Thomas Olencki, DO ‡ The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute Roberto Pili, MD † Roswell Park Cancer Institute Bruce G. Redman, DO † University of Michigan Comprehensive Cancer Center Cary N. Robertson, MD ω Duke Comprehensive Cancer Center Charles J. Ryan, MD † UCSF Helen Diller Family Comprehensive Cancer Center Lawrence H. Schwartz, MD ф Memorial Sloan-Kettering Cancer Center Joel Sheinfeld, MD ω Memorial Sloan-Kettering Cancer Center Jue Wang, MD † UNMC Eppley Cancer Center at The Nebraska Medical Center NCCN ®肾癌 肿瘤学临床实践指南(中国版)2010年 第一版 © National Comprehensive Cancer Network, Inc. All rights reserved. These guidelines and this illustration may not be reproduced in any form without the express written permission of NCCN. The Chinese edition 2010 is the collaborative outcome of the National Comprehensive Cancer Network and Chinese key opinion leaders of the field. Translated and adapted with permission and endorsement from the National Comprehensive Cancer Network. To view the most recent and complete version of this or any other guideline, visit www.nccn.org. NCCN特别鸣谢 NCCN指南中国版专家组 召集人: 孙 燕 中国医学科学院北京协和医学院 肿瘤医院 NCCN代表: Timothy M. Kuzel, MD Robert H. Lurie Comprehensive Cancer Center of Northwestern University NCCN肾癌临床实践指南(中国版)专家组 组长: 那彦群 北京大学首钢医院 秦叔逵 中国人民解放军第八一医院 成 员(按拼音排序): 陈 嘉 江苏省肿瘤医院 何志嵩 北京大学附属第一医院 黄翼然 上海交通大学医学院附属仁济医院 焦顺昌 中国人民解放军总医院(三〇一医院) 李 鸣 北京大学临床肿瘤学院、北京肿瘤医院 孙 光 天津医科大学附属第二医院 孙颖浩 第二军医大学附属长海医院 执笔人: 马建辉 中国医学科学院北京协和医学院肿瘤医院 郭 军 北京大学临床肿瘤学院、北京肿瘤医院 王金万 中国医学科学院北京协和医学院肿瘤医院 谢晓冬 沈阳军区总医院 叶定伟 复旦大学附属肿瘤医院 叶章群 华中科技大学同济医学院附属同济医院 于世英 华中科技大学同济医学院附属同济医院 张沂平 浙江省肿瘤医院 周芳坚 中山大学附属肿瘤医院 NCCN ® 肿瘤学临床实践指南(中国版)2010年 第一版 © National Comprehensive Cancer Network, Inc. All rights reserved. These guidelines and this illustration may not be reproduced in any form without the express written permission of NCCN. The Chinese edition 2010 is the collaborative outcome of the National Comprehensive Cancer Network and Chinese key opinion leaders of the field. Translated and adapted with permission and endorsement from the National Comprehensive Cancer Network. To view the most recent and complete version of this or any other guideline, visit www.nccn.org. 肾癌 目录 NCCN肾癌专家组成员 NCCN特别鸣谢 指南更新概要 检查、初始治疗和随访(KID-1) 复发和由于内科或外科原因无法手术切除的IV期肾癌的一线治疗(KID-2) 透明细胞为主型肾癌的后续治疗(KID-3) 手术治疗原则(KID-A) 根据UISS风险组划分制定的局限性和局部进展性肾癌患者的术后监测方案及 UISS风险组划分(KID-B) 影响生存期的不良因子(KID-C) 分期 讨论 参考文献 临床试验:NCCN认为任何肿瘤患者都可以在临床试验中得到最 佳处理,因此特别鼓励肿瘤患者参加临床试验研究。 NCCN对证据和共识的分类: 除非特别指出,NCCN对所有建议均达成2A类共识。 见NCCN对证据和共识的分类 作为共识,NCCN肿瘤学临床实践指南反映了作者们对目前认可的治疗方法的观点,欲参考或应用这些指南的临床医师应根据个人具体的临床情况做出独立的医疗判断,以决定患者所需的护理和治 疗。任何寻求使用这些指南的患者或非医生人员应咨询医生关于它们的合理应用。 NCCN肿瘤学临床实践指南编译力求精确表达反映原版英文指南。NCCN不保证指南编译的有效性,也不承认任何无限制性的担保、表达及暗示。NCCN不担保指南编译或指南本身的精确性和完整 性。NCCN不保证或担保或陈述指南的应用及应用结果。NCCN及其成员不对涉及指南无限制性应用的任何偶然的、间接的、特殊的、惩罚性或作为结果的补偿费承担任何责任。 声明: 本指南中标注“※”处为中国专家根据国内实际情况进行明显 改动或补充之处,内容有别于英文版,参考时请注意。 ...